Position in TLRY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,072,833
-$663,314 QoQ
Shares Held
461,656
+9.2% QoQ
Ownership
0.339%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 235 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. TLRY ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
5,294,529 | $2,868,734,637 | |
| 2 | ZTS |
Zoetis Inc.
|
39,430,181 | $2,833,452,797 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
13,711,607 | $2,310,954,234 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
63,894,301 | $2,164,738,910 | |
| 5 | ALKS |
Alkermes plc.
|
29,235,739 | $1,531,952,715 | |
| 6 | VTRS |
Viatris Inc
|
86,019,468 | $1,365,989,144 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
48,849,973 | $1,202,197,829 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
28,703,514 | $995,150,823 |
All Filings in TLRY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,072,833 | 461,656 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,736,147 | 422,898 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,452,950 | 493,129 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,057,168 | 2,923,221 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,155,912 | 2,819,307 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,804,471 | 2,734,053 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $3,375,984 | 2,538,337 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $4,660,060 | 2,647,763 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||